106 related articles for article (PubMed ID: 21355626)
21. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
Yang Y; Wang J; Zhang X; Lu W; Zhang Q
J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
[TBL] [Abstract][Full Text] [Related]
22. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
Almawash SA; Mondal G; Mahato RI
Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
[TBL] [Abstract][Full Text] [Related]
23. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
24. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
25. Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft models.
Zhang B; Dong S; Cen X; Wang X; Liu X; Zhang H; Zhao X; Wu Y
Anticancer Drugs; 2012 Jul; 23(6):590-6. PubMed ID: 22241170
[TBL] [Abstract][Full Text] [Related]
26. In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel.
Zhang J; Qian Z; Gu Y
Nanotechnology; 2009 Aug; 20(32):325102. PubMed ID: 19620759
[TBL] [Abstract][Full Text] [Related]
27. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z
Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
29. Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel.
Liu J; Zahedi P; Zeng F; Allen C
J Pharm Sci; 2008 Aug; 97(8):3274-90. PubMed ID: 18064681
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
Springate CM; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
33. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
34. Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model.
Song SY; Kim KP; Jeong SY; Park J; Park J; Jung J; Chung HK; Lee SW; Seo MH; Lee JS; Jung KH; Choi EK
Oncotarget; 2016 Nov; 7(47):77348-77357. PubMed ID: 27764799
[TBL] [Abstract][Full Text] [Related]
35. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
[TBL] [Abstract][Full Text] [Related]
37. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
[TBL] [Abstract][Full Text] [Related]
38. The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulations.
Arentsen HC; Hendricksen K; Hulsbergen-van de Kaa CA; Reddy G; Oosterwijk E; Alfred Witjes J
Urol Oncol; 2012; 30(1):64-8. PubMed ID: 19945311
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model.
Wang H; Isaji T; Satoh M; Li D; Arai Y; Gu J
Urology; 2013 Jan; 81(1):210.e11-5. PubMed ID: 23102779
[TBL] [Abstract][Full Text] [Related]
40. The multilayer nanoparticles formed by layer by layer approach for cancer-targeting therapy.
Oh KS; Lee H; Kim JY; Koo EJ; Lee EH; Park JH; Kim SY; Kim K; Kwon IC; Yuk SH
J Control Release; 2013 Jan; 165(1):9-15. PubMed ID: 23103984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
